← FDA Drug Approvals (Drugs@FDA)
RAPAFLO
NDA · New Drug Application · Sponsor: ABBVIE · Approved 2008-10-08
Drug application
- FDA Application #
NDA022206- Application type
- New Drug Application
- Brand name
- RAPAFLO
- Generic name
- Silodosin
- Active ingredients
- SILODOSIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ABBVIE
- First approval
- 2008-10-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown